发明授权
US07385085B2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
失效
肟衍生物取代的羟乙基胺天冬氨酰蛋白酶抑制剂
- 专利标题： Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
- 专利标题（中）： 肟衍生物取代的羟乙基胺天冬氨酰蛋白酶抑制剂
-
申请号： US11177324申请日： 2005-07-11
-
公开(公告)号： US07385085B2公开(公告)日： 2008-06-10
- 发明人: Varghese John , Michel Maillard , Barbara Jagodzinska , Jose Aquino , Gary Probst , Jay Tung
- 申请人： Varghese John , Michel Maillard , Barbara Jagodzinska , Jose Aquino , Gary Probst , Jay Tung
- 申请人地址： US CA South San Francisco
- 专利权人： Elan Pharmaceuticals, Inc.
- 当前专利权人： Elan Pharmaceuticals, Inc.
- 当前专利权人地址： US CA South San Francisco
- 代理机构： Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.
- 主分类号： C07C237/04
- IPC分类号： C07C237/04
摘要：
The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
公开/授权文献
信息查询
